CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- 4 Grant or award Director acquired 4,100 shares (grant or award)
- 4 Grant or award Director acquired 4,100 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 9,617 shares at $31.62 ($304,090)
- 4 Grant or award General Counsel acquired 16,250 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 15,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 31,250 shares (grant or award)
- 4 Grant or award President acquired 31,250 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 65,000 shares (grant or award)
- 4 Gift President gave 350,000 shares (gift)
- 4 Open-market sale Chief Operating Officer sold 34,822 shares at an average $41.48 ($1,444,369)
- 4 Open-market sale General Counsel sold 1,109 shares at an average $40.12 ($44,497)
- 4 Open-market sale Chief Financial Officer sold 1,106 shares at an average $40.12 ($44,376)
- 4 Open-market sale President sold 1,973 shares at an average $40.12 ($79,164)
- 4 Open-market sale Chief Operating Officer sold 12,678 shares at an average $40.12 ($508,684)
- 4 Open-market sale Chief Executive Officer sold 5,242 shares at an average $40.12 ($210,328)
- 4 Open-market sale Chief Operating Officer sold 47,500 shares at an average $35.35 ($1,678,914)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 2,915 shares at an average $23.89 ($69,650)
Page 9 of 15 · 290 filings